Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)

ClinicalTrials.gov ID: NCT00947882

Public ClinicalTrials.gov record NCT00947882. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Dose-Finding, Multi-Centre, Double-Blind, Randomised, Parallel, Placebo-Controlled Trial to Investigate Efficacy and Safety of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)

Study identification

NCT ID
NCT00947882
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
404 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Degarelix 10 mg Drug
  • Degarelix 20 mg Drug
  • Degarelix 30 mg Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2009
Primary completion
Feb 28, 2011
Completion
May 31, 2011
Last update posted
Jun 7, 2015

2009 – 2011

United States locations

U.S. sites
15
U.S. states
9
U.S. cities
15
Facility City State ZIP Site status
Urology Centers of Alabama, PC Homewood Alabama
Coastal Clinical Research Inc Mobile Alabama
California Professional Research Newport Beach California
Genitourinary Surgical Consultants Denver Colorado
Urology Associates , PC Englewood Colorado
South Florida Medical Research Aventura Florida
Winter Park Urology Associates Orlando Florida
Pinellas Urology Inc St. Petersburg Florida
Florida Urology Partners Tampa Florida
Northwestern University Chicago Illinois
Weill Cornell Medical College New York Presbyterian New York New York
Hudson Valley Urology, PC Poughkeepsie New York
Duke University Medical Center Durham North Carolina
Patient Priority Clinical Sites, LLC Cincinnati Ohio
Carolina Urologic Research Center Myrtle Beach South Carolina

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00947882, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 7, 2015 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00947882 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →